Stay updated on Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial
Sign up to get notified when there's something new on the Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial page.

Latest updates to the Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial page
- Check3 days agoChange DetectedRevision updated to v3.0.2; 'Back to Top' link removed.SummaryDifference0.5%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.5%
- Check18 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information.SummaryDifference61%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%
- Check39 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.11, indicating a revision in the content.SummaryDifference0.3%
- Check46 days agoChange DetectedThe page has been updated to include a new HHS Vulnerability Disclosure and has been revised to version 2.16.10, replacing the previous version 2.16.6. Additionally, a service alert regarding planned maintenance has been removed.SummaryDifference5%
Stay in the know with updates to Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial page.